The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74)
- PMID: 11773063
- DOI: 10.1074/jbc.C100714200
The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74)
Abstract
The substantial variations in the responses of cells to the anaphylatoxin C5a and its desarginated form, C5adR(74), suggest that more than one type of cell surface receptor for these ligands might exist. However, only a single receptor for C5a and C5adR(74), CD88, has been characterized to date. Here we report that the orphan receptor C5L2/gpr77, which shares 35% amino acid identity with CD88, binds C5a with high affinity but has a 10-fold higher affinity for C5adR(74) than CD88. C5L2 also has a moderate affinity for anaphylatoxin C3a, but cross-competition studies suggest that C3a binds to a distinct site from C5a. C4a was able to displace C3a, suggesting that C5L2, like the C3a receptor, may have a low binding affinity for this anaphylatoxin. Unlike CD88 and C3a receptor, C5L2 transfected into RBL-2H3 cells does not support degranulation or increases in intracellular [Ca(2+)] and is not rapidly internalized in response to ligand binding. However, ligation of C5L2 by anaphylatoxin did potentiate the degranulation response to cross-linkage of the high affinity IgE receptor by a pertussis toxin-sensitive mechanism. These results suggest that C5L2 is an anaphylatoxin-binding protein with unique ligand binding and signaling properties.
Similar articles
-
C5L2, a nonsignaling C5A binding protein.Biochemistry. 2003 Aug 12;42(31):9406-15. doi: 10.1021/bi034489v. Biochemistry. 2003. PMID: 12899627
-
Ligand specificity of the anaphylatoxin C5L2 receptor and its regulation on myeloid and epithelial cell lines.J Biol Chem. 2006 Dec 22;281(51):39088-95. doi: 10.1074/jbc.M609734200. Epub 2006 Oct 26. J Biol Chem. 2006. PMID: 17068344
-
The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein.J Biol Chem. 2003 Mar 28;278(13):11123-9. doi: 10.1074/jbc.M206169200. Epub 2003 Jan 22. J Biol Chem. 2003. PMID: 12540846
-
C5L2: a controversial receptor of complement anaphylatoxin, C5a.FASEB J. 2013 Mar;27(3):855-64. doi: 10.1096/fj.12-220509. Epub 2012 Dec 13. FASEB J. 2013. PMID: 23239822 Review.
-
Functions of C5a receptors.J Mol Med (Berl). 2009 Apr;87(4):375-8. doi: 10.1007/s00109-009-0442-7. Epub 2009 Feb 3. J Mol Med (Berl). 2009. PMID: 19189071 Free PMC article. Review.
Cited by
-
A pro-inflammatory role of C5L2 in C5a-primed neutrophils for ANCA-induced activation.PLoS One. 2013 Jun 13;8(6):e66305. doi: 10.1371/journal.pone.0066305. Print 2013. PLoS One. 2013. PMID: 23785491 Free PMC article.
-
Complement System Part I - Molecular Mechanisms of Activation and Regulation.Front Immunol. 2015 Jun 2;6:262. doi: 10.3389/fimmu.2015.00262. eCollection 2015. Front Immunol. 2015. PMID: 26082779 Free PMC article. Review.
-
Transcriptional control of complement receptor gene expression.Immunol Res. 2007;39(1-3):146-59. doi: 10.1007/s12026-007-0078-z. Immunol Res. 2007. PMID: 17917062 Review.
-
Expression of complement protein C5a in a murine mammary cancer model: tumor regression by interference with the cell cycle.Cancer Immunol Immunother. 2005 Oct;54(10):1026-37. doi: 10.1007/s00262-005-0672-7. Epub 2005 May 3. Cancer Immunol Immunother. 2005. PMID: 15868168 Free PMC article.
-
Neutralizing endogenous chemokines with small molecules. Principles and potential therapeutic applications.Pharmacol Ther. 2010 Apr;126(1):39-55. doi: 10.1016/j.pharmthera.2009.12.003. Epub 2010 Feb 1. Pharmacol Ther. 2010. PMID: 20117133 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous